TCL Archive By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure July 23, 2010
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive “Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes November 1, 1974
TCL Archive Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money December 2, 1983
